WO2024200811 - METHOD TO SCREEN, DIAGNOSE OR MONITOR TREATMENT USING INCREASED NUMBERS OF DEVIATING ANALYTES
National phase entry is expected:
Publication Number
WO/2024/200811
Publication Date
03.10.2024
International Application No.
PCT/EP2024/058760
International Filing Date
29.03.2024
Title **
[English]
METHOD TO SCREEN, DIAGNOSE OR MONITOR TREATMENT USING INCREASED NUMBERS OF DEVIATING ANALYTES
[French]
MÉTHODE DE DÉPISTAGE, DE DIAGNOSTIC OU DE SUIVI D'UN TRAITEMENT UTILISANT UN NOMBRE ACCRU D'ANALYTES DIVERGENTS
Applicants **
UNIVERSITEIT GENT
Sint-Pietersnieuwstraat 25
9000 Gent, BE
Inventors
MESTDAGH, Pieter
UGent – Department of Biomolecular Medicine
Corneel Heymanslaan 10
9000 Gent, BE
VANDESOMPELE, Joke
UGent – Department of Biomolecular Medicine
Corneel Heymanslaan 10
9000 Gent, BE
MORLION, Annelien
UGent – Department of Biomolecular Medicine
Corneel Heymanslaan 10
9000 Gent, BE
Priority Data
23165846.9
31.03.2023
EP
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 934 | |
| EPO | Filing, Examination | 4634 | |
| Japan | Filing | 533 | |
| South Korea | Filing | 576 | |
| USA | Filing, Examination | 2635 |
Total: 9312 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to the field of methods to screen, diagnose or monitor treatment of disease. More in particular, the present invention discloses methods wherein an increased number of analytes demonstrating deviating amounts in a biofluid or tissue sample is used to determine whether an individual is diseased.[French]
La présente invention se rapporte au domaine des méthodes de dépistage, de diagnostic ou de suivi du traitement d'une maladie. Plus particulièrement, la présente invention concerne des méthodes dans lesquelles un nombre accru d'analytes démontrant des quantités divergentes dans un échantillon de biofluide ou de tissu biologique est utilisé pour détecter une maladie chez un individu.